A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness ...

But patients with obesity would rather use Zepbound to ease their apnea ...